Today: 20 January 2026
Subscribe
Browse Category

Analyst Predictions News 8 October 2025

90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions

90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions

Current News & October 2025 Updates EMA Positive Opinion: A major recent catalyst for Acurx came on September 30, 2025, when the EMA’s Paediatric Committee issued a positive opinion on the Pediatric Investigation Plan (PIP) for Acurx’s lead drug, ibezapolstat, in Clostridioides difficile infection Investing. This essentially means European regulators agree with Acurx’s plan to study ibezapolstat in children, a prerequisite for future marketing approval in Europe. As…
8 October 2025
····
1 … 3 4 5

Stock Market Today

  • SunOpta (TSE:SOY) Stock Dips Below 200-Day Moving Average Amid Mixed Financials
    January 20, 2026, 4:36 AM EST. SunOpta Inc.'s (TSE:SOY) stock price slipped below its 200-day moving average, closing at C$6.42 against a threshold of C$7.25. The Canadian plant-based and fruit-based foods producer faces pressure with a high debt-to-equity ratio of 252.92 and a negative return on equity of 11.64%. Quarterly earnings showed C$0.05 per share on revenues of C$286.38 million, but the company recorded a net margin loss of 2.74%. Market analysts maintain a Hold rating, while noting a Price-to-Earnings ratio of 642, indicating elevated valuation concerns. SunOpta's market capitalization stands at approximately C$758.95 million, with mixed prospects as investors watch for performance shifts amid industry competition.
Go toTop